Glaxo bowel drug linked to array of side effects
GlaxoSmithKline and its partner Adolor said on Monday their drug to treat gastrointestinal side effects of opioid painkillers was linked to higher risk of heart attacks and other serious heart problems, fractures and skin cancers in a late-stage trial.
bdnews24.com News Service
bdnews24.com
Published :
10 Apr 2007, 12:09 PM
Updated :
17 Aug 2022, 02:52 PM
NEW YORK, April 10 (bdnews24.com/Reuters) - GlaxoSmithKline and its partner Adolor said on Monday their drug to treat gastrointestinal side effects of opioid painkillers was linked to higher risk of heart attacks and other serious heart problems, fractures and skin cancers in a late-stage trial.
The drugmakers said the negative findings came from a year-long Phase III study of their experimental drug, alvimopan, involving 805 patients experiencing bowel dysfunction as a result of taking opioids for treatment of chronic non-cancer pain.
bdnews24.com/mir/1345 h